How have COGT and MIRM total returns compared?

Over the past 5 years, COGT delivered 28.51% and MIRM delivered 37.24% annualized total return. Past performance doesn't predict future results.

Cogent Biosciences, Inc. (COGT) vs Mirum Pharmaceuticals, Inc. (MIRM)

A side-by-side comparison of Cogent Biosciences, Inc. and Mirum Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

COGT

Cogent Biosciences, Inc.

$5.19B

$30.37HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

MIRM

Mirum Pharmaceuticals, Inc.

$4.84B

$79.41HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT

Total return — COGT vs MIRM

growth of $100 · dividends reinvested · last 7y

COGT +192.3% (+16.6%/yr)MIRM +516.4% (+29.7%/yr)MIRM compounded faster over this window

COGT MIRM

COGT vs MIRM: by the numbers

•COGT is the larger company ($5.19B vs $4.84B market cap).
•Both run net losses; COGT's is the smaller (0.00% vs -139.18% net margin).

Metrics side by side

Valuation

Metric	COGT	MIRM
P/S ratio	N/A	7.83
P/B ratio	11.09	N/A

Profitability

Metric	COGT	MIRM
Gross margin	0.00%	81.70%
Operating margin	0.00%	-4.25%
Net margin	0.00%	-139.18%
ROE	-70.85%	N/A
ROIC	-50.09%	-13.09%

Growth (annualized)

Metric	COGT	MIRM
Revenue CAGR (5Y)	N/A	123.86%
Total return CAGR (5Y)	28.51%	37.24%

Frequently asked

How have COGT and MIRM total returns compared?: Over the past 5 years, COGT delivered 28.51% and MIRM delivered 37.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full COGT analysis Full MIRM analysis Interactive comparison tool

Dig into the metrics

Cogent Biosciences ROE Mirum Pharmaceuticals ROE Cogent Biosciences operating margin Mirum Pharmaceuticals operating margin Cogent Biosciences revenue growth Mirum Pharmaceuticals revenue growth Cogent Biosciences free cash flow Mirum Pharmaceuticals free cash flow

Cogent Biosciences & Mirum Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.